Ligand Pharmaceuticals (LGND) Change in Inventory (2011 - 2026)

Ligand Pharmaceuticals (LGND) has 16 years of Change in Inventory data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 728.0% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (up 79.22% YoY), and the FY2025 full-year result was -$5.0 million, up 48.14% from the prior year.
• Change in Inventory climbed to $4.1 million in Q1 2026, from -$2.8 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $13.0 million in Q2 2023 to a low of -$9.7 million in Q2 2022.
• A 5-year average of -$685588.2 and a median of -$1.4 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 4525.0% in 2023 and surged 728.0% in 2026, its largest moves.
• Tracing LGND's Change in Inventory over 5 years: stood at -$1.4 million in 2022, then surged by 47.86% to -$707000.0 in 2023, then plunged by 262.94% to -$2.6 million in 2024, then decreased by 8.11% to -$2.8 million in 2025, then surged by 249.24% to $4.1 million in 2026.
• Business Quant data shows LGND's Change in Inventory at $4.1 million in Q1 2026, -$2.8 million in Q4 2025, and -$3.6 million in Q3 2025.